Results 161 to 170 of about 195,935 (298)

Obstetrics and gynecology devices designed for low‐ and middle‐income countries: A narrative review

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 71-80, April 2025.
Abstract There are many barriers contributing to poor health outcomes for women in low‐ and middle‐income countries (LMICs), one of which is the lack of necessary medical devices. Presently, the development of various kinds of devices intended to improve women's health outcomes specifically in LMICs remains underrepresented in the literature; therefore,
Dhanalakshmi Thiyagarajan, Enaam A. Adanu, K. Rivet Amico   +2 more
wiley   +1 more source

Exploring Spanish-speaking patients' perspectives on obstetric anesthesia patient education materials. [PDF]

BMC Anesthesiol
Restrepo M, Pai S, A Scott T, W Burnett G.   +3 more
europepmc   +1 more source

Optimal timing for induction of labor in normotensive women: A retrospective cohort study

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 365-371, April 2025.
Abstract Objective Labor induction is offered to reduce the risk of stillbirth at late term (41+0 to 41+6) but earlier induction in normotensive singleton pregnancies is supported by weak evidence. The aim of the present study was to investigate the optimal timing for induction in normotensive women.
Jóhanna Gunnarsdóttir, Emma Marie Swift, Alexander Smárason, Kristjana Einarsdóttir   +3 more
wiley   +1 more source

Maternal and Neonatal Outcomes Associated With Cesarean Versus Vaginal Delivery in the United States: A Population-Based Retrospective Cross-Sectional Analysis of CDC Natality Public Use Data (2017-2020). [PDF]

Cureus
Isikwei E, Igetei JE, Asade OO, Ebere-Bank D, Asamoah-Twum AS, Oladimeji A, Oyelese IA, Okobi OE.   +7 more
europepmc   +1 more source

The rising tide: Trends in induction of labor at term over a 5‐year period at a single centre

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 383-390, April 2025.
Abstract Objective Induction of labor (IOL) is a controversial topic in contemporary obstetric practice, with some suggesting that the increase in elective induction (eIOL) as a potential contributor to increasing cesarean delivery (CD) rates. The objectives of this single‐center study were to examine the rates of IOL, trends in indications for IOL ...
Sarah M. Nicholson, Susan Hatt, Etaoin M. Kent, Michael P. Geary, Patrick Dicker, Zara E. Molphy, Karen Flood, Fergal D. Malone   +7 more
wiley   +1 more source

Balancing anatomical limits and dynamic adaptation: Understanding the determinants of successful vaginal breech delivery. [PDF]

Eur J Obstet Gynecol Reprod Biol X
Rothkamm MS, Maschke SK, Steinkasserer L, Renz D, Biermann AL, Radomsky L, Dütemeyer V, von Kaisenberg C, Hillemanns P, Brodowski L.   +9 more
europepmc   +1 more source

Iron deficiency with and without anemia in pregnancy: A scoping review of prevalence and perinatal impact

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background The prevalence of iron deficiency with anemia and iron deficiency without anemia (IDWA) during pregnancy have not been summarized, and evidence of the direct association of IDWA with adverse perinatal outcomes (APO) are unknown.
Lucky O. Lawani, David M. Naimark, Joel G. Ray, Jessica Widdifield, Paul Eze, Chidumebi J. Idemili, Nadine Shehata   +6 more
wiley   +1 more source

Stillbirths by maternal-obstetric characteristics and Robson classification system: a cross-sectional study from eight district hospitals in Bangladesh. [PDF]

J Glob Health
Hossain L, Mallick T, Sayeed A, Kader ML, Al-Zubayer MA, Azrin F, Mahmood HR, Jahan MS, Dewan F, Shovon MMHK, Saha N, Rahman F, Sajib MRUZ, Hawlader MDH, Mitra D, Sarker MMH, El Arifeen S, Rahman AE, Ahmed A.   +18 more
europepmc   +1 more source

Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective In the dose‐escalation part of Study 101, which included multiple tumor types, objective responses were observed in 10 of 22 patients across multiple dose levels of farletuzumab ecteribulin (FZEC). We explored the safety/antitumor activity of FZEC in patients with platinum‐resistant ovarian cancer (PROC) from the Study 101 expansion ...
Kan Yonemori, Mayu Yunokawa, Koji Matsumoto, Kazuhiro Takehara, Kosei Hasegawa, Yasuyuki Hirashima, Hidenori Kato, Hiroki Ikezawa, Yohei Otake, Wataru Yusa, Takuma Miura, Shin Nishio   +11 more
wiley   +1 more source

Outcomes and Risk Factors for Failed Trial of Labour After One Previous Caesarean Section in Selected Private Hospitals in Mogadishu, Somalia: An Unmatched Case-Control Study. [PDF]

Int J Womens Health
Adawe MMM, Ibrahim FH, Garba B, Mudei NM, Mohamoud JH, Elmi AH.   +5 more
europepmc   +1 more source